Related Experiment Video
Updated: Mar 18, 2026
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Usefulness of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in dermatofibrosarcoma
Raghava Kashyap1, Vamshi Krishna Muddu2, Sameera Anantamakula1
1Department of Nuclear Medicine and Positron Emission Tomography, Mahatma Gandhi Cancer Hospital, Visakhapatnam, Andhra Pradesh, India.
Abstract:
Dermatofibrosarcoma protuberans (DFSP) is a rare locally aggressive tumor with distant metastases being unusual. We present a case of metastatic DFSP treated with imatinib showing complete metabolic response to treatment.
Insights
Dermatofibrosarcoma protuberans (DFSP) is a rare aggressive tumor. A metastatic DFSP case showed a complete metabolic response to imatinib treatment.
Area of Science:
- Oncology
- Medical Research
Background:
- Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer.
- DFSP is known for local aggressiveness, with distant metastases being uncommon.
Observation:
- This report details a unique case of DFSP with distant metastases.
- The patient's metastatic DFSP was treated with imatinib.
Findings:
- The treatment with imatinib resulted in a complete metabolic response.
- This indicates significant efficacy of imatinib in managing metastatic DFSP.
Implications:
- This case highlights imatinib as a potential therapeutic option for metastatic DFSP.
- Further research into imatinib's role in advanced DFSP is warranted.
